These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12742856)

  • 1. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide.
    Jonas JB; Kreissig I; Degenring R
    Arch Ophthalmol; 2003 May; 121(5):729-30. PubMed ID: 12742856
    [No Abstract]   [Full Text] [Related]  

  • 2. Argon laser trabeculoplasty for intractable glaucoma following intravitreal triamcinolone.
    Viola F; Morescalchi F; Staurenghi G
    Arch Ophthalmol; 2006 Jan; 124(1):133-4. PubMed ID: 16401800
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant glaucoma as a complication of intravitreal triamcinolone acetonide.
    Heatley CJ; Lim KS; Siriwardena D; Barton K
    Acta Ophthalmol Scand; 2006 Oct; 84(5):712-3. PubMed ID: 16965510
    [No Abstract]   [Full Text] [Related]  

  • 4. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone acetonide and secondary ocular hypertension.
    Jonas J; Heatley G; Spaide R; Varma R
    J Glaucoma; 2005 Apr; 14(2):168-71. PubMed ID: 15741821
    [No Abstract]   [Full Text] [Related]  

  • 6. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
    Gregori NZ; Rosenfeld PJ; Puliafito CA; Flynn HW; Lee JE; Mavrofrides EC; Smiddy WE; Murray TG; Berrocal AM; Scott IU; Gregori G
    Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intravitreal triamcinolone acetonide on intraocular pressure.
    Bakri SJ; Beer PM
    Ophthalmic Surg Lasers Imaging; 2003; 34(5):386-90. PubMed ID: 14509462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection.
    Yang CS; Chen MJ; Chou CK; Hsu WM
    Ophthalmologica; 2005; 219(6):413-5. PubMed ID: 16286805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
    Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.
    Quiram PA; Gonzales CR; Schwartz SD
    Am J Ophthalmol; 2006 Mar; 141(3):580-2. PubMed ID: 16490518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
    Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of intractable glaucoma following intravitreal triamcinolone acetonide.
    Agrawal S; Agrawal J; Agrawal TP
    Am J Ophthalmol; 2005 Mar; 139(3):575-6; author reply 576. PubMed ID: 15767088
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
    Jonas JB; Akkoyun I; Budde WM; Kreissig I; Degenring RF
    Arch Ophthalmol; 2004 Feb; 122(2):218-22. PubMed ID: 14769599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone and elevated intraocular pressure.
    Wingate RJ; Beaumont PE
    Aust N Z J Ophthalmol; 1999 Dec; 27(6):431-2. PubMed ID: 10641903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone.
    Spaide RF
    Ophthalmology; 2008 Aug; 115(8):1436; author reply 1436-7. PubMed ID: 18675704
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
    Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA
    Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular pressure rise after intravitreal triamcinolone.
    Vedantham V
    Am J Ophthalmol; 2005 Mar; 139(3):575; author reply 576. PubMed ID: 15767089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.